All Eyes On Pricing Model As EU Crunch Time Nears For First Ophthalmic Bevacizumab

 
• By Neena Brizmohun
  
EU flag reflected in eye
EMA to decide on EU marketing application for wet AMD drug Lytenava • Source: Shutterstock

More from Products

More from Generics Bulletin